VivoSeq
Other

Sore Throat

0

Pipeline Programs

4

Active Trials

3

Companies Involved

Sore Throat is an early-stage landscape with 0 programs across 3 companies. The most active players are Boehringer Ingelheim, Pfizer, Sanofi.

Pipeline Metrics

Competitive Density

16/100

Pipeline Velocity

6/100

Mech. Concentration

N/A

Completion Rate

90/100

Attrition Rate

7/100

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

Programs by Phase

No pipeline programs currently tracked for this disease.

Trial Status

15

clinical trials

Completed9 · 60%
Recruiting2 · 13%
Not yet recruiting2 · 13%
Unknown status1 · 7%
Withdrawn1 · 7%

Trial Activity

15 trials

the Impact of Ketamine Gargling on the Incidence of Post Intubation Sore Throat
Not yet recruiting··N/A·NCT06368843·80 enrolled
Ibuprofen Lozenge in Acute Sore Throat Pain
Completed·PPierre Fabre Medicament·Phase 3·NCT01785862·427 enrolled
Ambroxol Spray Sore Throat Study
Completed·Boehringer Ingelheim logoBoehringer Ingelheim·Phase 2·NCT01361802·494 enrolled
Sore Throat Prevention Following Intubation
Completed·UUniversity of Jordan·Phase 4·NCT02682134·300 enrolled
KRYSTAL- KetopRofen lYsinate Sore ThroAt Lozenges
Completed·Sanofi logoSanofi·Phase 3·NCT00929877·801 enrolled
Acute Sore Throat Pain Study
Completed·PPierre Fabre Medicament·Phase 2·NCT01535079·186 enrolled
Effect of Clove Oil and Menthol Lozenges on Post-extubation Sore Throat
Unknown status··Phase 1·NCT06811051·150 enrolled

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)